Dr. Barney J. Stern is a neurologist specializing in vascular neurology and neurological complications of sarcoidosis. His work in vascular neurology has covered all aspects of stroke management, including prevention and acute, subacute and chronic care. Dr. Stern also provides complex care management for patients suffering from neurosarcoidosis. His research focuses on understanding the biology and clinical outcomes of neurovascular disease and neurological complications associated with sarcoidosis. Dr. Stern has served as the medical safety monitor on a number of National Institutes of Health (NIH) stroke studies. In his new role at Johns Hopkins, Dr. Stern will be seeing outpatients as a member of the Advanced Clinical Neurology division with Dr. John Probasco. Dr. Stern is rated as an Elite provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Neurosarcoidosis, Stroke, Herpes Zoster Oticus, Arachnoiditis, and Thrombectomy.

Dr. Pardo's interest in transverse myelitis centers on management of acute myelitis, biomarkers of the disease in cerebrospinal fluid (CSF) and blood, and the role of neuroimmune factors in the pathogenesis of myelopathies. Along with others neurologists and health care providers in the Johns Hopkins Transverse Myelitis Center, Dr. Pardo focuses on a comprehensive approach in the diagnosis and management of myelopathies, myelitis, neuroimmunological and neuroinfectious disorders. Dr. Pardo is rated as an Elite provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Acute Flaccid Myelitis (AFM), Neurosarcoidosis, Transverse Myelitis, Zika Virus Disease, and Gastrostomy.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Dr. Michelle Sharp practices Pulmonary and Critical Care Medicine. Her primary area of interest is sarcoidosis, and she has experience in the diagnosis and treatment of sarcoidosis in all of its forms, and the management of consequences of this systemic disease. The Johns Hopkins Sarcoidosis Clinic serves to coordinate management of patients with multi-organ involvement with sarcoidosis, and to this end Dr. Sharp maintains clinical and research collaborations with Cardiology, Neurology, and Ophthalmology. Dr. Sharp received her B.S. from Tulane University. She earned her M.D. from the Louisiana State University School of Medicine. She completed her residency and fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Sharp is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Neurosarcoidosis, Sarcoidosis, Necrotizing Granuloma, and Lung Metastases.

Dr. Chen practices Pulmonary and Critical Care Medicine. His primary area of interest is sarcoidosis, and he has extensive experience in the diagnosis and treatment of sarcoidosis in all of its forms, and the management of consequences of this systemic disease. The Sarcoidosis Clinic often serves to coordinate management of patients with multi-organ involvement with sarcoidosis, and to this end Dr. Chen actively maintains clinical and research collaborations with Cardiology, Cardiovascular Nuclear Medicine, Neurology, and Ophthalmology. Additionally, Dr. Chen participates as a Physician Champion in the Johns Hopkins Health System Epic project to improve the safety and quality of care of critically ill patients through optimization of the electronic medical record. His work involves developing systems-based approaches to complex management issues, including sepsis and severe alcohol withdrawal. Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lung Metastases, and Acute Interstitial Pneumonia.

Neurologist Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He works within the Division of Neuroimmunology and Neurological Infections at The Johns Hopkins Hospital, and has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica and stiff person syndrome. After completing fellowship training, Dr. Newsome joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, and he is the director of the Johns Hopkins Neurosciences Consultation and Infusion Center and the Stiff Person Syndrome Center. He is also director of the Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program and co-director of the Multiple Sclerosis Experimental Therapeutics Program. Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine, with honors. During his neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award, and later was chosen to be chief resident. He subsequently completed a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship Award from the National Multiple Sclerosis Society. Identifying and testing novel therapies and therapeutic strategies for multiple sclerosis and other neuroimmunological disorders is Dr. Newsome’s main research focus. Other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis and identifying risk factors of disease onset and severity, response to treatment and long-term outcomes in neuroimmunological disorders. An adviser for the National Multiple Sclerosis Society and a member of the Miller-Coulson Academy of Clinical Excellence, Dr. Newsome has also served as president of the Consortium of Multiple Sclerosis Centers. Dr. Newsome is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Stiff Person Syndrome, Multiple Sclerosis (MS), Transverse Myelitis, and Relapsing Multiple Sclerosis (RMS).

Amal Hassan Ahmed Awadalla, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Faculty of Medicine University of Khartoum, and completed her residency at Queens Hospital Center. Dr. Awadalla is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Neurosarcoidosis, and Sarcoidosis.

Dr. Buescher is a pulmonary critical care physician. He has been deeply involved in clinical teaching of both medical students, interns, residents and fellows throughout his career. He is the director of the Medical/Surgical Critical Care Units at MedStar Union Memorial Hospital as well as MedStar Good Samaritan Hospital. He is president of a large community private practice pulmonary and critical group (Pulmonary and Critical Care Associates of Baltimore) He serves at Hopkins on the part-time clinical faculty. Research Summary Dr. Buescher is involved in multiple clinical research projects. Dr. Buescher is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lung Metastases, Endoscopy, and Gastrostomy.

Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant.

Nancy Lin is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Sarcoidosis, Neurosarcoidosis, Beryllium Disease, and Interstitial Lung Disease.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Dr. Angeliki Filippatou specializes in the diagnosis, management and treatment of neuroimmunological disorders with a particular focus on multiple sclerosis (MS). Her research focuses on the development of innovative prognostic and monitoring biomarkers for MS and related neuroimmunological conditions, including the integration of emerging digital health tools into disease tracking. Dr. Filippatou earned her medical degree from the National and Kapodistrian University of Athens, Greece and went on to complete her neurology residency at the Johns Hopkins Hospital. She pursued subspecialty fellowship training in neuroimmunology at Johns Hopkins. Her fellowship training was supported by the National Institutes of Health/ National Institute of Neurological Disorders and Stroke and the National MS Society. Dr. Filippatou is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Optic Neuritis, Multiple Sclerosis (MS), Transverse Myelitis, Neuromyelitis Optica, and Thrombectomy.

Dr. Jonathan Orens is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pulmonary and critical care medicine. He is an internationally recognized expert in lung transplantation. Dr. Orens received his M.D. from the University of Maryland School of Medicine. He completed his residency at the University of Maryland Medical Center and performed a fellowship in pulmonary and critical care medicine at the University of Michigan Hospitals. Dr. Orens joined the Johns Hopkins faculty in 1998. His research interests include clinical outcomes of lung transplantation, chronic allograft rejection and ischemic reperfusion injury. Dr. Orens is rated as an Experienced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Lung Transplant, and Endoscopy.

Dr. Pali Dedhiya Shah is a pulmonary and critical care physician. She is an expert in the diagnosis and treatment of advanced lung disease and lung transplantation. She is the medical director of the Johns Hopkins Lung Transplant program. She is a member of the International Society for Heart and Lung transplantation and provides teaching to medical students, residents and fellows at Johns Hopkins. Dr. Shah earned her medical degree from Jefferson Medical College of Thomas Jefferson University. She completed her residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Shah joined the Johns Hopkins faculty as an assistant professor of medicine in 2011. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Endoscopy.

Brenda Banwell is the director of the Department of Pediatrics, as well as pediatrician-in-chief and co-director of Johns Hopkins Children’s Center, where she helps manage the hospital’s many clinical and research centers. Dr. Banwell is a renowned expert in the research and treatment of pediatric multiple sclerosis (MS) and other neuroimmune disorders. She specializes in and studies the use of neuroimaging to assess the clinical and cognitive impact of the conditions, as well as the function of the immune system in children with these disorders. She also created a standardized clinical care algorithm and clinical database in order to evaluate the clinical impact of MS. Dr. Banwell has published more than 250 manuscripts in high-impact journals, along with over 25 book chapters. In addition, she has over 200 national and international invited lectureships and visiting professorships. An advocate for pediatric multiple sclerosis needs and research, Dr. Banwell serves as chair of the International Medical and Scientific Board of the Multiple Sclerosis International Federation, and the Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD) International Research Consortium. She is also chair of the pediatric committee of the National Institutes of Health NeuroNEXT program, which conducts studies on treatments for neurological diseases through academic, private, and industry collaborations. Dr. Banwell currently serves as past-chair of the International Pediatric Multiple Sclerosis Study Group, Dr. Banwell earned her medical degree from the University of Western Ontario. She later completed a residency in pediatrics at the University of Western Ontario-Children's Hospital of Western Ontario and a second residency in pediatric neurology at University of Toronto – The Hospital for Sick Children. Her residencies were followed by a fellowship in neuromuscular research at Mayo Clinic. Dr. Banwell is rated as an Experienced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Multiple Sclerosis (MS), CACH Syndrome, Optic Neuritis, and Transverse Myelitis.

Karisa Schreck is co-director of the BRAF Brain Tumor Center at Johns Hopkins. Her research focuses on the development of small-molecule targeted therapies for patients with primary brain tumors. Dr. Schreck has specific expertise in the treatment of BRAF gene mutations. As such, she works with Christine Pratilas’ laboratory to investigate resistance mechanisms to BRAF-targeted therapy. Dr. Schreck also writes and runs clinical trials for novel targeted agents through the Comprehensive Brain Tumor Center and the Alliance for Clinical Trials in Oncology. Dr. Schreck is rated as an Experienced provider by MediFind in the treatment of Neurosarcoidosis. Her top areas of expertise are Glioma, Brain Tumor, Astrocytoma, and Glioblastoma.

Dr. Merlo is an internist who specializes in pulmonary and critical care medicine. Dr. Merlo also has clinical expertise in the care of patients with cystic fibrosis as well as clinical expertise in the care of patients with advanced lung disease who may require or have undergone lung transplantation. Dr. Merlo holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Merlo attended the College of the Holy Cross and completed medical school and residency training in internal medicine at Georgetown University. He completed both clinical and research fellowships in pulmonary and critical care medicine at Johns Hopkins, and earned his M.P.H. at the Bloomberg School of Public Health. His research interests include outcomes in lung transplantation and cystic fibrosis, HIV-related pulmonary disease, and outcomes in Osler Weber Rendu. Dr. Merlo serves as the Associate Program Director of Scholarship for the Osler Medical Housestaff Training Program. He has contributed numerous scientific papers and book chapters related to cystic fibrosis and lung transplantation, and his awards include the Harry Shwachman Clinical Investigator Award from the Cystic Fibrosis Foundation. Dr. Merlo is rated as an Experienced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Aspergillosis, Lung Transplant, and Endoscopy.

Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is rated as an Experienced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Lung Transplant.

Albert Polito is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Polito is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease, and Acute Interstitial Pneumonia.

Nevins Todd is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Todd is rated as an Advanced provider by MediFind in the treatment of Neurosarcoidosis. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pneumonia, Sarcoidosis, and Endoscopy.